NI-203

N/A

Report date: 2025/07/01 15:17:09

Base Information

Drug NameNI-203
Drug Alias NameNI-203
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionIslet amyloid polypeptide inhibitors
TargetsIslet amyloid polypeptide
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeurimmune Ag
China Registration ClassN/A

Develop Information

Active CompaniesNeurimmune Ag
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A